Market closed
Solventum Corporation/$SOLV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Solventum Corporation
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
Ticker
$SOLV
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
22,000
Website
SOLV Metrics
BasicAdvanced
$13B
26.80
$2.76
-
-
Price and volume
Market cap
$13B
52-week high
$96.05
52-week low
$47.16
Average daily volume
1.2M
Financial strength
Current ratio
1.202
Quick ratio
0.737
Long term debt to equity
266.847
Total debt to equity
276.546
Interest coverage (TTM)
2.98%
Management effectiveness
Return on assets (TTM)
5.01%
Return on equity (TTM)
6.55%
Valuation
Price to earnings (TTM)
26.801
Price to revenue (TTM)
1.552
Price to book
4.32
Price to tangible book (TTM)
-2.14
Price to free cash flow (TTM)
15.915
Growth
Revenue change (TTM)
0.70%
Earnings per share change (TTM)
-64.57%
3-year revenue growth (CAGR)
0.34%
What the Analysts think about SOLV
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Solventum Corporation stock.
SOLV Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
SOLV Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
SOLV News
AllArticlesVideos
Billionaire Nelson Peltz Has 67% of His Hedge Fund's $3.9 Billion Portfolio Invested in Just 3 Stocks
24/7 Wall Street·2 weeks ago
Solventum Corporation (SOLV) Q4 2024 Earnings Call Transcript
Seeking Alpha·3 weeks ago
Solventum forecasts annual profit above estimates on strong surgical product sales
Reuters·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Solventum Corporation stock?
Solventum Corporation (SOLV) has a market cap of $13B as of March 23, 2025.
What is the P/E ratio for Solventum Corporation stock?
The price to earnings (P/E) ratio for Solventum Corporation (SOLV) stock is 26.8 as of March 23, 2025.
Does Solventum Corporation stock pay dividends?
No, Solventum Corporation (SOLV) stock does not pay dividends to its shareholders as of March 23, 2025.
When is the next Solventum Corporation dividend payment date?
Solventum Corporation (SOLV) stock does not pay dividends to its shareholders.
What is the beta indicator for Solventum Corporation?
Solventum Corporation (SOLV) does not currently have a Beta indicator.